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Running head  
Experiences of TOP self-management in Scotland  
 
ABSTRACT  
Objective To explore the experiences of women in Scotland who return home to complete medical 
termination of pregnancy (TOP) ≤63 days of gestation, after being administered with mifepristone 
and misoprostol at an NHS TOP clinic.  
Design Qualitative interview study.  
Setting One National Health Service health board (administrative) area in Scotland.  
Population or Sample Women in Scotland who had undergone medical TOP ≤63 days, and self-
managed passing the pregnancy at home; recruited from three clinics in on NHS health board area 
between January and July 2014.  
Methods In-depth, semi-structured interviews with 44 women in Scotland who had recently 
undergone TOP ≤63 days of gestation, and who returned home to pass the pregnancy. Data were 
analysed thematically using an approach informed by the Framework method. 
Main Outcome Measures Women’s experiences of self-management of TOP ≤63 days of gestation.  
Results Key themes emerging from the analysis related to self-administration of misoprostol in clinic; 
reasons for choosing home self-management; facilitation of self-management and expectation-
setting; experiences of getting home; self-managing and monitoring treatment progress; support for 
self-management (in person and remotely); and pregnancy self-testing to confirm completion.   
Conclusions Participants primarily found self-administration of misoprostol and home self-
management to be acceptable and/or preferable, particularly where this was experienced as a 
decision made jointly with health professionals. The way in which home self-management is 
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presented to women at clinic requires ongoing attention. Women could benefit from the option of 
home administration of misoprostol.  
Keywords Termination of pregnancy (TOP), first trimester medical/medication abortion, home self-
management, women’s experiences, qualitative research  
Tweetable abstract (max 110 chars): Women undergoing medical TOP 63 days found home self-
management to be acceptable &/or preferable. 
 
INTRODUCTION 
Recent World Health Organisation guidance includes the option of home self-management for first 
trimester medical termination of pregnancy (TOP).1 However, the current interpretation of British 
legislationi – the 1967 Abortion Act which governs provision in Scotland, Wales and England – is that 
both TOP medications (mifepristone and misoprostol) must be administered on National Health 
Service (NHS) premises. With the development of safe, reliable treatment regimens for TOP ≤63 days 
of gestation  has come the option for women in Britain to return home to self-manage passing the 
pregnancy, after misoprostol has been administered at an outpatient clinic.  
Research suggests that women self-managing first trimester TOP have varied experiences, 2,3,4    but 
are no more likely to re-attend with complications than those treated in hospital.5 While a growing 
body of literature suggests that self-management is acceptable to women,2,7-17 there is an need to 
monitor and understand women’s needs around this model of provision, to facilitate provision of the 
best possible support. Our research contributes to this understanding, by examining details of 
women’s experiences of self-management ≤63 days, of which relatively little to date is known.  
                                                            
i We deliberately use ‘Britain’/’British’ here, rather than ‘UK’, since the latter includes Northern Ireland, where 
access is much more severely restricted.  
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In Britain, home self-management is becoming increasingly established practice, and is now the 
default option for eligible women in many NHS and independent clinics.ii,14,15 Women are also 
commonly given the option to vaginally self-administer misoprostol at the clinic. This paper draws on 
data from one Scottish NHS health board area, where women are typically treated over two clinic 
visits,18,19 and in which around 77% of TOP ≤63 days (55% of all terminations) are completed at 
home.5 The first visit involves counselling and administering mifepristone; and the second provision 
of misoprostol and post-TOP contraception.18 At the time of fieldwork, clinic protocol specified that 
women should be given a choice between home self-management and hospital care.  
The objective of the wider study was to evaluate provision of TOP ≤63 days from the perspectives of 
women and health professionals.18,19 This paper focuses on the former, with the aim of 
understanding and exploring women’s experiences, in order to inform service developments and 
future provision, where TOP has until recently been provided exclusively in a hospital setting.  
 
METHOD 
A qualitative research design offered flexibility to women in discussing their experiences of TOP in 
their own words.20 Recruiting sites – one community sexual and reproductive health (SRH) clinic, two 
hospital-based clinics in one NHS area – served an urban/peri-urban population, with women 
typically travelling for less than one hour to attend, and had been offering home self-management 
for approximately 18 months prior to this study. Specialist health professionals provided study 
details to women attending for medical TOP ≤63 days, under Ground C of the 1967 Abortion Act (i.e. 
                                                            
ii In some circumstances women may remain in hospital as a ‘day case’: for example if she has a higher 
likelihood of medical complications; if she lives more than an hour from a hospital; if there are concerns about 
her safety or she has no-one to be with her; or if she speaks limited English.   
 iii Our sample thus represents approximately 5% of all women (n=867) who had medical abortion ≤63 days in 
the recruiting area within the six month recruitment period (figure provided by Information Service Division, 
personal communication 8/2/2017). Two interviewees were excluded from the analysis presented here as they 
had received hospital treatment.  
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for psychosocial rather than medical indications). Over a six month recruitment period (January–July 
2014), 135 women completed an ‘opt-in’ contact form, agreeing to be contacted by CP at a later 
date. CP made contact approximately two weeks later to arrange an interview. Six women were 
ineligible, two explicitly withdrew, and 81 were un-contactable within the specified six week 
timeframe. We did not conduct purposive sampling beyond the aim of recruiting an equal number of 
women who had presented in each of two clinical contexts (hospital and community SRH), 
comparison of which was of interest to the broader study.  Interviews were conducted three to five 
weeks following TOP, in a location of the woman's choosing or by telephone. Recruitment and 
interviewing continued until data saturation was achieved; that is, when no new findings emerged 
from new data collected. Written consent was obtained prior to the interviews. 
A flexible topic guide was developed in light of literature reviews and input from the study Advisory 
Group. Interviews explored TOP experiences, including interaction with health professionals; home 
self-management; and contraception.17 Interviews were digitally recorded and transcribed in full. 
Participants received a £15 voucher as compensation for their time.  
A thematic analytical approach informed by the Framework method20 was undertaken by CP and JH, 
who repeatedly read interview transcripts, before meeting to discuss and compare interpretations, 
and identify key themes. A coding framework was developed and applied to transcripts based on 
initial themes identified. Coded datasets were further analysed to identify linkages between themes 
and explore similarities and differences across accounts. NVivo 10 qualitative data analysis software 
(QSR International 2012, Melbourne, Victoria, Australia) facilitated coding and data management. 
Where data extracts are presented, identifiers in brackets indicate participant identifier and age. 
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RESULTS  
We conducted in-depth interviews with 44 women who had recently undergone medical TOP ≤63 
days,iii and who had self-managed passing the pregnancy at home. Key characteristics of participants 
are outlined in Table 1.  
[Table 1 here]   
Issues relating to self-management were clustered around two broad themes, namely women’s 
introduction to self-management at the clinic, and experiences of self-management at home. Our 
analysis addresses different components of each, including: misoprostol self-administration at clinic; 
choosing home self-management; expectation-setting by health professionals; getting home; self-
management and monitoring treatment progress; support for self-management; and home 
pregnancy testing to confirm completion.  
 
Introducing self-management at the clinic 
Misoprostol self-administration: “I was happy to do it myself” 
For most participants, a degree of self-management began with vaginal self-administration of 
misoprostol at clinic. There was variation in the degree to which women felt this was optional and/or 
standard practice. Most saw it as relatively unproblematic, and were relieved to self-administer. 
However, some described feeling nervous about inserting the tablets correctly and preferred the 
nurse to do this:  
                                                            
iii Our sample thus represents approximately 5% of all women (n=867) who had medical abortion ≤63 days in 
the recruiting area within the six month recruitment period (figure provided by Information Service Division, 
personal communication 8/2/2017). Two interviewees were excluded from the analysis presented here as they 
had received hospital treatment.  
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I says “well, to be honest, I would rather you did, because at least I know it’s done properly.” 
So she went “that’s no problem”.’ (SR21, 43)  
Self-administration, combined with a relatively brief appointment, led some to question why 
misoprostol could not be provided to take home at the mifepristone appointment, rather than 
having to re-attend 1-2 days later:  
Why does it have to take that long if I'm putting the pills in myself? […] Why can they not 
give you that on that day and say “tomorrow, stick these four pills up you”? Just to go in and 
do that for five minutes seems pointless to me. (H111, 26) 
Why home self-management? “I’d rather be in the privacy of my own home”  
Some participants reported initial surprise that home self-management was an option. The vast 
majority of women said that the privacy and comfort of their own surroundings was their preferred 
option:  
What they’d said was – and I was in agreement – “You’d probably be way more comfortable 
at home. […] “You can do it in a hospital environment...” But 100% I’d much rather be at 
home with a telly and some ice-cream.  It’s good to have the option, but definitely at home 
[you’re] much more comfortable in your own bed. (SR22, 21)  
Some participants were concerned with making undue use of NHS resources.  
I didn’t want to go to the hospital because I didn’t want to take up a bed for six hours. I was 
really conscious of wasting the NHS’s time, because I felt… like that was not necessary, and it 
was my own fault. (SR20, 21)  
Some women also preferred to go home because they felt uncomfortable about the hospital TOP 
service’s location adjacent to maternity services, and were worried about being judged by service 
users.  
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There was, again, variation in the extent to which women perceived home self-management as 
optional. Some understood this to be the default treatment mode, with day wards reserved for 
exceptional cases. This included a minority who felt that they had not been given, or been able to 
request, day ward treatment.  
I really wanted to stay in, but I never got the option for it. I think they maybe should let 
people stay in to definitely make sure it’s all away […] I never mentioned it because I knew 
they weren’t going to let me stay in. They were like “it’s very rare for people to stay in.”  So 
they were just like “see you later, go home” basically. (H115, 22)  
However, the presentation of home self-management as the default care pathway left most feeling 
relatively safe and unconcerned:  
I don't remember feeling like I had a choice. It pretty much just sounded like: “this is the 
normal procedure, this is what we do.” So I wasn’t concerned. (H107, 30) 
 
Expectation-setting: “I felt fully informed”  
For all women who self-managed at home, information and advice from health professionals were 
crucial in assuring their comfort with this option. Participants described how health professionals 
had provided substantial amounts of information, with the appointment feeling like ‘lots of bits of 
paper, lots of pills’ (SR20, 21). As well as providing analgesics, much of the information related to 
expectation-setting, and  advising women of circumstances in which they should seek help, which 
left most participants feeling appropriately informed:  
 They explain everything to you. I got a brown bag full of information. She spoke to me for 
about 20 minutes: emergency numbers, absolutely everything. (H104, 23)  
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As a result of health professionals’ frank descriptions, participants also reported having a clear sense 
of what was ‘normal’:  
She was very matter-of-fact about it, she said: “Within 15 minutes once you’d inserted the 
tablets you’ll start getting symptoms and the pain will build up. You’ll probably start 
bleeding quite a lot. Then, over the next four hours, you should pass a very large clot, or 
several large clots. Once that’s happened the pain should start dissipating […] They give you 
a scenario where you’re bleeding out more than you should be and therefore you should be 
phoning up. (SR23, 38)  
Where experiences at home were congruent with what women had been given to expect, they 
reported these experiences as broadly acceptable. After they had received these descriptions, 
factors about which participants said that they had continued to feel anxious or unsure included 
what expulsion would feel like, and what the pregnancy tissue would look like (see below).  
 
Home self-management 
Women’s accounts of self-management focused around pain, bleeding and passing the pregnancy, 
echoing experiences from clinic settings.22 Here we focus on how these experiences were shaped by 
their passing the pregnancy at home. 
 
Getting home: “I started feeling quite ill in the car” 
Participants described a range of experiences when travelling home from the clinic following 
misoprostol administration. Several felt nauseous or started cramping, while others recalled severe 
pain beginning:  
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Oh it started in the car […] I was in agony, I was saying to my partner 'oh my god, it's kicking 
in, I'm getting really bad pains!' So I got home and I just got into my pyjamas and went 
straight into bed (H206, 25) 
While some women were relatively untroubled by the onset of symptoms during the journey – 
viewing it as a necessary evil, endured in order to get home – others felt frightened,  upset or 
exposed. For women who knew no-one with a car and/or could not afford a taxi, coping with the 
onset of pain and bleeding on public transport was particularly challenging and frustrating:  
When I was on the bus I could feel that I was bleeding a lot […]I was really tired.  I was just 
kind of, y’know: “I’ve spent 45 minutes on a bus for a two-minute appointment..?”  (SR06, 
27)  
 
Being at home:  “Being at home is really the best thing”  
The vast majority of women said they valued the option to return home, as it had afforded them 
dignity and privacy that they expected would be absent in hospital:  
It’s such a physical and emotional process so, y’know, at home’s better. Hugely. You basically 
need to like make friends with your toilet for eight hours, so it kind of works at home better.  
(SR02, 37)  
[It was] definitely the right decision.  I think that would be so much more traumatic if you did 
that in a hospital. (CP: In what sort of way, d’you think?) I just think it would be so… not 
‘humiliating’, that’s not the right word, but just so public. I was such a mess. I would be so 
embarrassed for people to see me like that… ’ (SR01, 21)  
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While not an absolute, those who reported that they might have preferred hospital-based care were 
also those whose experiences were less congruent with the expectations set by clinic staff, and who 
did not necessarily feel that they had been given a choice.  
 
Monitoring treatment progress: “Like two almighty periods in eight hours” 
Many women noted the importance of the information provided by nurses which prepared them for 
the process, and enabled them to assess its progression: 
It’s good to do it at home, but I think a good level of honesty from the nurse [is helpful], 
because it’s on the cusp of being cope-able with. (SR23, 38) 
 In the absence of a nurse’s assessment, bleeding was perceived as an indicator of efficacy. Having 
been briefed that bleeding was likely to be very heavy, some women had concerns about whether 
treatment had worked when bleeding was relatively light. A minority described surprise at the 
volume of bleeding, and some difficulty managing this:  
That day was absolutely horrific. I bled so much. I didn't think it'd be as much as that and as 
much clotting and stuff. I was literally sitting on the toilet for half an hour at a time, because 
every time you stood up it just was pouring out […] You couldn’t get to the bathroom fast 
enough, it was just coming in force. [...] I had to go in the shower cause I'd leaked, and then 
you're standing in the shower and it's just pouring out and obviously you're seeing all the 
clots and I'm like “oh my god!”. (H202, 22)  
 
Several participants reported that – as clinic staff advised they would – they had recognised when 
they had passed the bulk of the pregnancy tissue, and this had brought relief. Others were unsure 
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whether this had occurred, and whether the TOP had been successful.  Some women reported 
unease at the unfamiliar sensation of passing larger clots: 
Y’know, sometimes if you’ve got your period, and you’re sitting still for ages, and you stand 
up and you can kind of feel it? It was sort of like that.  But I was on the toilet and it almost 
felt a little bit like… jelly, a little bit clotted. (SR10, 26) 
Many women reported being advised by health professionals not to look at what they had passed, or 
that there would be nothing to see at such an early gestation. A small minority reported seen what 
they believed to be a recognisable fetus, were distressed by this, and regretted looking:  
[I] just felt compelled, that I had to look. So that's when I knew [TOP had been effective]. […] 
In hindsight I wish I hadn't looked but I did, and that was probably the most traumatic thing 
I've ever seen or done. I thought “what on earth..?” (H201, 35)  
 
Support in person: “going through it together” 
Participants reported that they had all been strongly advised to have an adult with them for 24 
hours after taking misoprostol, and the majority were supported at home to varying degrees by their 
partner (and a smaller number by a female friend/family member). Some reported that male 
partners had found the process challenging –feeling ‘useless’ or ‘helpless’ (H107, 30) –  and some 
voiced a preference for hospital care, even where this was not the woman’s preference. Those in 
relatively new relationships felt embarrassment that their partner had seen them go through the 
more visceral aspects of medical TOP, but nevertheless felt grateful that they had been able to 
through it together at home.  
While most had someone stay with them, some had preferred to be alone, and felt that having 
another person present would create additional distress:   
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[Friend] wanted to stay but I told her to go home, and I was so glad I did, because if she'd 
been in here and seen me screaming like that, she'd have phoned an ambulance. She 
would’ve panicked  (H201, 35)  
Women in this position nonetheless had someone nearby and available by phone.   
Support at a distance: “Knowing that I could pick up the phone at any time helped” 
Many participants reported being informed at clinic that telephone support would be available from 
clinic staff if needed, though not all had required it: 
[The] senior nurse gave me her mobile number and told me I could ring her if I wanted, if I 
had any questions, or if I was worried about anything, or if anything unexpected happened 
[…]  So I thought that was a really nice, like, “OK, I’m not alone here”.  (SR01, 21) 
For those who sought support, the reassurance provided by nurses was generally felt to be 
invaluable, particularly where experiences differed from what had been expected.  
I phoned them […] and I says to them “listen, is this [ongoing cramping] normal? I know that 
you gave me painkillers but I expected to maybe take them on the [day] but not so many 
days later.”  And they were like “it’s totally normal […] it’s absolutely fine.” So again, [this] 
put my mind at ease. (SR21, 43)  
Whether or not women had sought phone support, they reported feeling reassured that this was an 
option, and that they would not be required to explain their situation, since those answering the call 
would be aware that they were undergoing TOP.  
 
Home pregnancy testing: “Thankfully it came back negative, so it’s all done and dusted”  
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All participants had been provided with a low-sensitivity urine pregnancy (LSUP) test to be 
performed two weeks after TOP. Some reported initial anxieties around self-administering the test:  
At first I did think “what if I do it wrong?” and “what if I still am?” and “would I prefer the 
professionals to do it?” But you couldn’t really do it wrong. And the symptoms sort of went 
away anyway, so I knew. So that was fine. (SRH21, 43) 
Several women had not taken the test as they felt the physical signs of pregnancy had dissipated, 
and thus judged that the treatment had been successful. Most said they were happy with the self-
test, because it both confirmed that they were no longer pregnant, and meant they would not 
require further contact with TOP services.  
 
 
DISCUSSION  
Main findings 
There is an urgent need to better understand what the shift toward self-management in abortion 
care means for women. Our analysis demonstrates that women see home self-management as 
beneficial, offering a potentially more comfortable space in which to go undergo TOP, and the 
opportunity to have support from a partner, friend or family member. Our findings highlight 
potential areas for improvement, primarily around the degree to which misoprostol self-
administration and home self-management are conveyed to women as optional. Our analysis 
suggests that, while home was the preferred option for most, it is essential that the alternative of 
hospital care is made clear. This potentially requires a delicate balancing act for health professionals 
between normalising home self-management and facilitating joint decision-making and choice. 
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Strengths and limitations 
A limitation to the study is that all women were recruited from one NHS health board area, where a 
significant proportion of women self-manage TOP ≤63 days and, at the time of fieldwork, home self-
management had been an option for over a year. It also drew on a relatively small sample which did 
not allow for comparison with hospital-managed care. Given the body of literature that suggests a 
tendency for recipients of healthcare to positively evaluate any care they receive,23 doing so may 
have produced a quite different picture. However, the richness of the data generated has enabled 
identification of a range of experiences, and new areas as yet unexplored in the literature on first 
trimester medical TOP.  
Interpretation (in light of other evidence) 
Our findings add weight to existing evidence which has suggested that women undergoing TOP ≤63 
days are largely amenable to self-management and that, while they may experience some initial 
anxieties, they tend to express overall satisfaction.2,24-26 Crucially, our analysis suggests that women 
value being given choices and feeling involved in decisions about their treatment,4,14,17,27,28 and goes 
some way to address concerns raised by providers about how women might cope at home.18 Our 
analysis also highlights that women’s perceptions of their overall experiences were more negative 
when self-management was not their preferred option, or they did not feel involved in treatment 
decision-making. This foregrounds the significance of offering women options in the TOP pathway, 
including whether and how to self-administer misoprostol (ie. vaginally or sublingually/bucally), and 
where to the pass the pregnancy.  
Our findings are supported by existing literatures which have highlighted the vital role which health 
professionals play in information provision and expectation-setting.27-29 They also underscore the 
importance to women embarking on TOP of feeling that they know what to expect, are in control, 
and that they have and are having an experience congruent with what they perceive health 
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professionals have led them to expect. Our findings resonate with research which suggests that 
much of women’s anxieties around TOP are grounded not in the decision to end the pregnancy, but 
in apprehension around an unknown process.27-30 Clearly informing women of what to expect of TOP 
is crucial to ensuring their safety and comfort, and to facilitating that sense of control.2,27,28 However, 
health professionals also need to convey the potential for variation in experiences of medical TOP, 
and are therefore required to strike a delicate balance between the specific detail that (some) 
women want, and the range of experiences that they may face. Effectively striking this balance 
simultaneously affords women greater agency in the process, and maintains the place of first 
trimester TOP self-management within the bounds of medical care.19  
One current gap in this regard appears to be around experiences of passing larger clots/pieces of 
pregnancy tissue. It may be that this remains a relatively taboo aspect of the process, which health 
professionals find more challenging to verbalise; or that this has not previously been flagged to 
providers as information which women undertaking self-management want. Either way, this 
emerged as a significant, and for many women surprising, component of first trimester medical TOP.   
Our analysis suggests that the comfort and privacy afforded by self-management enabled women to 
cope with treatment in a way that suited them, without concerns about how they were being 
perceived by strangers, as they might in a hospital setting. This echoes the suggestion that self-
management can facilitate alternative experiences of TOP.2 Significantly, our findings shed further 
light on the essential role of available support (in this case by telephone) from health professionals 
during and following TOP.2 Given the potential variability of women’s experiences of pain and 
bleeding, it is vital that those undergoing self-management have the option to seek advice and 
reassurance as needed. The invaluable role that this support played for women in our study also 
underlines the implications for those to whom such a service is not available, and where TOP is not 
legally provided.4   
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Safe medical regimens offer advantages to women undergoing first trimester TOP, and the potential 
to develop self-management further. In the British context, however, the current interpretation of 
the 1967 Abortion Act requires TOP medications to be administered on NHS premises. Hence, the 
opportunity to extend self-management – to include, for example, home administration of 
misoprostol – is currently constrained, despite the significant issues an additional clinic visit can 
create for women.31 Given the significant changes in provision in the 50 years since it was passed, we 
echo the suggestion14 that the 1967 Abortion Act and its interpretation should be revisited, in order 
to facilitate further improvement in patient-centred TOP care.  
 
CONCLUSION  
This study explored the experiences of women who had self-managed medical TOP ≤63 days of 
gestation, in a context where provision has until recently been hospital-based. Our findings highlight 
that women valued self-management, from self-administration of misoprostol at clinic, through 
passing the pregnancy, to confirming TOP completion via a self-performed LSUP test. It also 
foregrounds the need to maintain high standards of information provision and appropriate support 
for women undergoing TOP in this model.  
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Table 1 Sample Characteristics  
Table 1. Sample characteristics  
Age (years)  Total (n=44) (% of total)  
- Mean 26.8
- Median 23
- Range  18-43
 
Highest education attained 
- Secondary school 14 31.9%  
- Further education (e.g. college)  13 29.5% 
- Higher education (i.e. university ) 13 29.5% 
- Postgraduate 4 9.1%
 
Relationship status (at interview)  
- Single 8 18.1%  
- Cohabiting/married 18 40.9% 
- In relationship (not cohabiting) 17 38.7
- Separated 1 2.3%  
 
Employment status  
- In paid employment 31 70.5% 
- Student  7 15.9%  
- Not in paid employment / full-time parent 6 13.6% 
 
Children  15 34.1%  
Previous abortion  7 15.9%  
 
 
